Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
about
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDTChemophototherapy: An Emerging Treatment Option for Solid TumorsIn vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform.Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugatesPhotodynamic therapy and cancer: a brief sightseeing tour.Targeted drug delivery in pancreatic cancerVerteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.Bioluminescence-activated deep-tissue photodynamic therapy of cancer.The role of photodynamic therapy in overcoming cancer drug resistance.Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cellsPorphyrin-related photosensitizers for cancer imaging and therapeutic applications.Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung CancerSimultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways.Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.Longitudinal, label-free, quantitative tracking of cell death and viability in a 3D tumor model with OCT.PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.Photosensitiser-antibody conjugates for photodynamic therapy.Novel aspect of chemophototherapy in treatment of cancer.Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications.Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer.Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer.Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral CellsAn Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy.Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.Multifunctional Conjugated Polymer Nanoparticles for Image-Guided Photodynamic and Photothermal Therapy.Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.Photoimmunotherapy and ovarian cancer: an improbable fiction or a palpable hit?Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.
P2860
Q27324380-85B33105-73C6-4E52-A4E6-E2DA1D93B1C7Q28468315-2D577156-82EA-4CE4-8450-D82BD33FE6C7Q30531713-1306A68A-6FA1-494D-BDCC-AA19E02103ACQ30574141-9A6CC368-D9BD-4926-925C-834FDAFCD875Q33276646-E26408E5-008E-4899-AEAE-78F63339B02BQ33625651-5A77852E-ADE5-488A-B3BF-DE7887F71C66Q34068126-35DEEC5E-9FE7-405F-9CE9-E77F396D8BEFQ34676773-2980F8E4-E8F2-44F1-A274-EBCF5763AF3EQ34780639-411316B3-7BC6-49DC-8408-CE94B79C0600Q35633335-2727E4D2-77A1-4093-B7E2-AF95D459567AQ35904547-B5F4F7A6-E621-4D79-A252-682D708D10BCQ35973340-0C999ECE-0D3B-440A-AA20-CD1D60547AA1Q36109127-3FF64407-0126-44C8-8D53-EF9B20B57EB3Q36394224-D45FC570-4706-4B2B-BB25-FC524ACC0A37Q36505652-14599348-0F2A-4F4F-AF7A-AB3D935EEEDFQ36641872-2EEA6A66-C7AE-447C-BAFF-C4CD9CBA6256Q36767541-DE34B74B-CB7A-4B06-9CEE-9900AB703D4CQ36790826-6CF67343-6B60-4A5A-AFD9-F08521E2271DQ36955529-62345B84-5160-4698-86AE-82B20DC564FBQ36983114-1D4155D8-AEDF-455F-8310-08B222099A57Q37115994-29C6EB99-5653-4853-ABEA-00F7852529E3Q37197458-8CE3529D-9378-495F-8554-3F8BB184CDC4Q37463677-D251B385-2DFF-4C02-8B19-029771F3B64CQ37853421-2770190D-9A5E-4EA8-ACF0-852B1819696CQ37970645-F6EAAFBC-4344-4ECB-A48E-1C749EF7BC50Q38328583-56FB0391-F9E6-4FD0-8224-EB51C4537BA9Q38699434-2981EFB0-B429-4EA4-9908-27A252829A9FQ38729867-CF81C98F-755F-4FDC-B9B9-3C9C9274F623Q39850358-B42A7BC1-69FE-42B2-912C-D9AEBC5EDB5FQ41779469-DDF27415-637C-4581-8A20-E485420785F7Q42656975-66696F3F-09AB-47C0-842F-057B05D559DEQ45875101-8F5E192C-206A-439E-98D3-6664B30B28A4Q50219051-A9E36918-3FD6-4718-B66D-31E8962B5EB7Q52715664-E1F22BCD-8E90-434C-87D1-5CE43CDAF716Q53900587-E5AE3347-F7CE-49E6-BC52-B9598EF46778Q55220021-4C5EB317-7246-4802-9424-22AF6BA84157
P2860
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@en
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@nl
type
label
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@en
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@nl
prefLabel
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@en
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@nl
P2093
P2860
P356
P1476
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
@en
P2093
P2860
P304
P356
10.1093/JNCI/91.18.1557
P407
P577
1999-09-01T00:00:00Z